Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 24 Jun 2021 – 20 Aug 2026, limited by Kotak Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 24 Jun 2021 | ₹100.00 | ₹100.00 |
| 28 Nov 2021 | ₹108.02 | ₹107.83 |
| 04 May 2022 | ₹105.92 | ₹105.62 |
| 08 Oct 2022 | ₹110.65 | ₹109.65 |
| 14 Mar 2023 | ₹108.90 | ₹107.93 |
| 18 Aug 2023 | ₹123.90 | ₹122.29 |
| 22 Jan 2024 | ₹138.73 | ₹136.93 |
| 26 Jun 2024 | ₹153.61 | ₹151.16 |
| 30 Nov 2024 | ₹155.67 | ₹152.82 |
| 06 May 2025 | ₹157.09 | ₹154.39 |
| 10 Oct 2025 | ₹163.97 | ₹160.13 |
| 16 Mar 2026 | ₹152.00 | ₹148.25 |
| 20 Aug 2026 | ₹158.33 | ₹153.46 |
| Metric | Kotak Mahindra · Regular NAV ₹15.86 Very High risk ★★★☆☆ | Category median Index Funds · 366 funds |
|---|---|---|
| -2.57% | +5.43% | |
| +8.50% | +8.41% | |
| +8.70% | +8.95% | |
| — | +11.28% | |
| +9.32% | +7.40% | |
| +7.08% | — | |
| +12.46% | +11.37% | |
| +9.25% | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 13.19% | 13.88% | |
| 0.15 | 0.25 | |
| 0.21 | 0.35 | |
| -16.63% | -16.66% | |
| Nifty 50 | — | |
| +0.61% | +0.30% | |
| 1.00 | 1.00 | |
| 101.5% | 101.3% | |
| 98.0% | 98.8% | |
| 0.38% | 0.96% | |
| ₹1,109Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 12% | 35% | |
| Abhishek Bisen | — | |
| 24 Jun 2021 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.